-- Earnings Flash (ABIO) ARCA BIOPHARMA Reports Q1 Loss $-0.23
4:18PM ET 5/02/2022 MT Newswires...
Arca Biopharma (ABIO) said Monday its board formed a special committee of directors to study potential strategic options to maximize stockholder value. ...
(Corrects to show correct name of Sage's drug candidate in third paragraph.) Health care stocks added to their midday gains this afternoon, with the NYSE...
Health care stocks added to their midday gains this afternoon, with the NYSE Health Care Index rising 0.6% while the SPDR Health Care Select Sector ETF...
Address | 10170 Church Ranch Way Westminster, Colorado 80021 |
Phone | +1.720.940.2200 |
Number of Employees | 15 |
Recent SEC Filing | 05/20/2022![]() |
President, Chief Executive Officer & Director | Michael R. Bristow |
Chief Operating Officer | Thomas A. Keuer |
Chief Financial Officer | C. Jeffrey Dekker |
Chief Medical Officer | Debra Marshall |
Price Open | $2.29 |
Previous Close | $2.32 |
52 Week Range | $1.71 - 3.90 |
Market Capitalization | $33.1 M |
Shares Outstanding | 14.4 M |
Sector | Health Technology |
Industry | Pharmaceuticals: Major | Next Earnings Announcement | 08/03/2022 |
Call Open Interest (1d)* | ![]() |
Put Open Interest (1d)* | ![]() |
Call Volume (1d)* | ![]() |
Put Volume (1d)* | ![]() |
Put Call Open Interest Ratio (1d)* | ![]() |
Put Call Volume Ratio (1d)* | ![]() |
* Data delayed by up to 15 minutes |
Price / Earnings | N/A |
Earnings per Share | -$1.28 |
Beta vs. S&P 500 | N/A |
Revenue | $0.00 |
Net Profit Margin | N/A |
Return on Equity | -34.12% |
Buy | |
Overweight | |
Hold | |
Underweight | |
Sell | |
Consensus Recommendation![]() |